Quarterly report · Q2
6776.TEDINET S100S8RZ
Period2023-04-01 → 2023-09-30
Filed2023-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥12.8bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥23.9bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥10.9bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Operating income | ¥502m | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | ¥266m | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | ¥726m | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥752m | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥445m | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥835m | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥464m | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥566m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥612m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥329m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥577m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | ¥311m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥29.0bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥27.6bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥23.3bn | at 2022-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥18.5bn | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥18.0bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥10.5bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥9.5bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥9.3bn | at 2022-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥5.5bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥5.5bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥5.5bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.6bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.8bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.1bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥1.1bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.7bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥472m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥1.7bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥4.2bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.5bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥327m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥2.8bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥544m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥33.28 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥19.43 | 2023-07-01 → 2023-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥35.99 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥19.39 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥13.23 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 30.0% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 28.8% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.1% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 41
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-09-30 | −¥21m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-09-30 | −¥21m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-09-30 | ¥2m |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Americareportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥2.2bn |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Americareportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥2.2bn |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Americareportable segment | segment profit | 2023-04-01 → 2023-09-30 | −¥2m |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Chinareportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥225m |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Chinareportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥225m |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Chinareportable segment | segment profit | 2023-04-01 → 2023-09-30 | −¥18m |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Japanreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥10.3bn |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Japanreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥10.3bn |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Japanreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥21m |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Japanreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥405m |
| jpcrp040300-q2r_E01813-000Real Estate Businessreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥142m |
| jpcrp040300-q2r_E01813-000Real Estate Businessreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥142m |
| jpcrp040300-q2r_E01813-000Real Estate Businessreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥115m |
| —segment total | revenue | 2023-04-01 → 2023-09-30 | ¥12.9bn |
| —segment total | revenue external | 2023-04-01 → 2023-09-30 | ¥12.8bn |
| —segment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥21m |
| —segment total | segment profit | 2023-04-01 → 2023-09-30 | ¥500m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-09-30 | −¥59m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-09-30 | −¥59m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-09-30 | ¥2m |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Americareportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥1.3bn |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Americareportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥1.3bn |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Americareportable segment | segment profit | 2022-04-01 → 2022-09-30 | −¥26m |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Chinareportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥430m |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Chinareportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥389m |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Chinareportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥40m |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Chinareportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥65m |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Japanreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥9.1bn |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Japanreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥9.1bn |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Japanreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥18m |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Japanreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥107m |
| jpcrp040300-q2r_E01813-000Real Estate Businessreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥143m |
| jpcrp040300-q2r_E01813-000Real Estate Businessreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥143m |
| jpcrp040300-q2r_E01813-000Real Estate Businessreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥117m |
| —segment total | revenue | 2022-04-01 → 2022-09-30 | ¥11.0bn |
| —segment total | revenue external | 2022-04-01 → 2022-09-30 | ¥10.9bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥59m |
| —segment total | segment profit | 2022-04-01 → 2022-09-30 | ¥263m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 498
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 17014000 | |
| Number of shares held | CurrentQuarterInstant_No1MajorShareholdersMember | 5712000 | |
| Shareholding ratio | CurrentQuarterInstant_No1MajorShareholdersMember | 0.3357 | |
| Number of shares held | CurrentQuarterInstant_No2MajorShareholdersMember | 2352000 | |
| Shareholding ratio | CurrentQuarterInstant_No2MajorShareholdersMember | 0.1382 | |
| Number of shares held | CurrentQuarterInstant_No3MajorShareholdersMember | 900000 | |
| Shareholding ratio | CurrentQuarterInstant_No3MajorShareholdersMember | 0.0528 | |
| Number of shares held | CurrentQuarterInstant_No4MajorShareholdersMember | 520000 | |
| Shareholding ratio | CurrentQuarterInstant_No4MajorShareholdersMember | 0.0305 | |
| Number of shares held | CurrentQuarterInstant_No5MajorShareholdersMember | 471000 | |
| Shareholding ratio | CurrentQuarterInstant_No5MajorShareholdersMember | 0.0277 | |
| Number of shares held | CurrentQuarterInstant_No6MajorShareholdersMember | 254000 | |
| Shareholding ratio | CurrentQuarterInstant_No6MajorShareholdersMember | 0.0149 | |
| Number of shares held | CurrentQuarterInstant_No7MajorShareholdersMember | 252000 | |
| Shareholding ratio | CurrentQuarterInstant_No7MajorShareholdersMember | 0.0148 | |
| Number of shares held | CurrentQuarterInstant_No8MajorShareholdersMember | 250000 | |
| Shareholding ratio | CurrentQuarterInstant_No8MajorShareholdersMember | 0.0146 | |
| Number of shares held | CurrentQuarterInstant_No9MajorShareholdersMember | 220000 | |
| Shareholding ratio | CurrentQuarterInstant_No9MajorShareholdersMember | 0.0129 | |
| Number of shares held | CurrentQuarterInstant_No10MajorShareholdersMember | 213000 | |
| Shareholding ratio | CurrentQuarterInstant_No10MajorShareholdersMember | 0.0125 | |
| Number of shares held | CurrentQuarterInstant | 11145000 | |
| Shareholding ratio | CurrentQuarterInstant | 0.6550 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | - | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | - | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | - | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | - | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsTreasurySharesEtcMember | - | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 17008400 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 170084 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 5600 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 17014000 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 170084 | |
| Cash and deposits | Prior1YearInstant | 5499000000 | JPY |
| Cash and deposits | CurrentQuarterInstant | 5475000000 | JPY |
| Notes and accounts receivable trade | Prior1YearInstant | 3585000000 | JPY |
| Notes and accounts receivable trade | CurrentQuarterInstant | 3763000000 | JPY |
| Electronically recorded monetary claims operating ca | Prior1YearInstant | 1541000000 | JPY |
| Electronically recorded monetary claims operating ca | CurrentQuarterInstant | 1810000000 | JPY |
| Finished goods | Prior1YearInstant | 842000000 | JPY |
| Finished goods | CurrentQuarterInstant | 1207000000 | JPY |
| Work in process | Prior1YearInstant | 188000000 | JPY |
| Work in process | CurrentQuarterInstant | 230000000 | JPY |
| Raw materials | Prior1YearInstant | 1006000000 | JPY |
| Raw materials | CurrentQuarterInstant | 1125000000 | JPY |
| Other ca | Prior1YearInstant | 419000000 | JPY |
| Other ca | CurrentQuarterInstant | 255000000 | JPY |
| Current assets | Prior1YearInstant | 13083000000 | JPY |
| Current assets | CurrentQuarterInstant | 13868000000 | JPY |
| Buildings and structures net | Prior1YearInstant | 4980000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |